Accretion PharmaceuticalsNSE:ACCPL -4.14%18 Days Payable is 23.34 as of Mar. 2026, which is 80% below its 10-year median of 114.01. GuruFocus rates NSE:ACCPL with a GF Score™ of 18/100. The stock has 6 warning signs investors should review. Among 922 Drug Manufacturers companies, Accretion Pharmaceuticals ranks worse than 93.38% on this metric.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:ACCPL vs LLY, JNJ, ABBV: Days Payable Comparison
For the Drug Manufacturers - General subindustry, Accretion Pharmaceuticals's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Accretion Pharmaceuticals Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Accretion Pharmaceuticals's Days Payable distribution charts can be found below:
* The bar in red indicates where Accretion Pharmaceuticals's Days Payable falls into.
Accretion Pharmaceuticals Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Accretion Pharmaceuticals's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Accretion Pharmaceuticals (NSE:ACCPL) has a Days Payable of 23.34 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Accretion Pharmaceuticals and its competitors. This is 80% below median its historical median of 114.01. Over the past decade, Accretion Pharmaceuticals' Days Payable has ranged from 23.64 to 140.04. According to the industry distribution chart, Accretion Pharmaceuticals ranks #861 out of 922 companies in the Drug Manufacturers industry, placing it in the top 93.4%.
Is Accretion Pharmaceuticals' Days Payable too high?
Accretion Pharmaceuticals' current Days Payable of 23.34 is 80% below median its 10-year median of 114.01. Over the past 10 years, this metric has ranged from a low of 23.64 to a high of 140.04. The Drug Manufacturers industry median Days Payable is 90.84. Accretion Pharmaceuticals' value of 23.34 is 74.3% below this industry median. Based on the distribution chart, Accretion Pharmaceuticals ranks #861 out of 922 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Accretion Pharmaceuticals has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Accretion Pharmaceuticals' Days Payable compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Accretion Pharmaceuticals ranks #861 out of 922 companies for Days Payable. This places Accretion Pharmaceuticals in the lower half of its industry. The industry median Days Payable is 90.84. Accretion Pharmaceuticals' value of 23.34 is 74.3% below this benchmark. Historically, Accretion Pharmaceuticals' own Days Payable has ranged from 23.64 to 140.04 over the past decade. While the company's 10-year median is 114.01 vs. the industry median of 90.84, Accretion Pharmaceuticals has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.84, based on 922 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Accretion Pharmaceuticals's current Days Payable of 23.34 is 74.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Accretion Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Accretion Pharmaceuticals's current Days Payable is 23.34, which is 80% below median its own 10-year median of 114.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Accretion Pharmaceuticals stock overvalued right now?
Accretion Pharmaceuticals (NSE:ACCPL) has a current Days Payable of 23.34. The current Days Payable is 23.34, which is 80% below median its 10-year median of 114.01 and 74.3% below the Drug Manufacturers industry median of 90.84. Accretion Pharmaceuticals' overall GF Score™ is 18/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Accretion Pharmaceuticals (NSE:ACCPL), the current Days Payable is 23.34 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Accretion Pharmaceuticals Ltd is engaged in the manufacturing of Medicinal & Pharmaceutical Products. The company manufactures tablets, oral liquid, capsule, cream, ointment, mouthwash, dusting powder, gel, ear drops, lotion, shampoo, powder, syrup, among others.
18GF Score
Get the complete analysis for NSE:ACCPL
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ACCPL has been successfully added to your 